Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05542251 · ClinicalTrials.gov registry record · NA
Education Program for Caregivers of Children With Gross Motor Delays
A NA study of Gross Motor Development Delay, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 3
- Study locations
NCT05542251: Completed NA study of Gross Motor Development Delay, sponsored by Emory University.
NCT05542251 is a NA study of Gross Motor Development Delay that has completed, run by Emory University. The registered enrollment target is 92 participants, above the 32-participant average among 3 other Gross Motor Development Delay trials with a reported enrollment target (188% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05542251, a NA study of Gross Motor Development Delay, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 3
- Study locations
Study Summary
The main objective of this project is to determine whether an educational intervention delivered via social media can improve parent understanding of child development and progression in child's developmental goals. A secondary objective is to determine whether this intervention can improve parent-related outcomes, such as well-being, parent-child bonding, attitudes toward parenting, satisfaction with the educational program.
Primary Outcome
Parent understanding of child development will be measured using a 24-item questionnaire with true/false and multiple choice questions. Total scores range from 0 to 24 and higher scores indicate better understanding of child development.
Conditions Studied
Interventions
- BEHAVIORAL Parent Educational Program
Study Locations (3)
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Emory Healthcare System - Atlanta
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2022-09-28 |
| Est. Completion | 2023-11-02 |
| Phase | NA |
What the finished NCT05542251 record still lists
NCT05542251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, above the 32-participant average among 3 other Gross Motor Development Delay trials with a reported enrollment target (188% higher).
The record links to 1 condition, with Gross Motor Development Delay appearing as the primary indexed condition, and to 1 intervention - of which Parent Educational Program is the first listed.
NCT05542251 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05542251 about?
NCT05542251 is a clinical study titled "Education Program for Caregivers of Children With Gross Motor Delays". The main objective of this project is to determine whether an educational intervention delivered via social media can improve parent understanding of child development and progression in child's developmental goals. A secondary objective is to determine whether this intervention can improve parent-r...
What is the current status of trial NCT05542251?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2022-09-28. Estimated completion is 2023-11-02.
What conditions does trial NCT05542251 study?
This clinical trial studies the following conditions: Gross Motor Development Delay.
What interventions are being tested in trial NCT05542251?
The interventions under investigation include: Parent Educational Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05542251?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05542251 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gross Motor Development Delay
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI